Similarly, in patients with laryngeal carcinomas treated with surgery and/or radiotherapy, Baer et al. [13] found a significant association between the immunohistochemical expression of SLC2A3 and survival. This evidence concerns the gene SLC2A3 and laryngeal carcinoma.